These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31370768)

  • 1. Letter by Wu et al Regarding Article, "Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus".
    Wu C; Ma H; Ji X
    Stroke; 2019 Sep; 50(9):e271. PubMed ID: 31370768
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Behrouz et Al regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
    Behrouz R; Mutgi SA; Silver B
    Stroke; 2015 Jun; 46(6):e149. PubMed ID: 25899241
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Chao AC; Po HL; Chan L
    Stroke; 2014 Dec; 45(12):e303. PubMed ID: 25342029
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter by Alves et al Regarding Article, "Effect of Right Insular Involvement on Death and Functional Outcome After Acute Ischemic Stroke in the IST-3 Trial (Third International Stroke Trial)".
    Alves JN; Pinho J; Ferreira C
    Stroke; 2017 Mar; 48(3):e91. PubMed ID: 28174329
    [No Abstract]   [Full Text] [Related]  

  • 5. Response by Sposato et al to Letter Regarding Article, "Effect of Right Insular Involvement on Death and Functional Outcome After Acute Ischemic Stroke in the IST-3 Trial (Third International Stroke Trial)".
    Sposato LA; Wardlaw JM; Hachinski V
    Stroke; 2017 Mar; 48(3):e92. PubMed ID: 28174325
    [No Abstract]   [Full Text] [Related]  

  • 6. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort.
    Cronin CA; Langenberg P; Dutta TM; Kittner SJ
    Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
    Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke.
    Berkowitz AL; Mittal MK; McLane HC; Shen GC; Muralidharan R; Lyons JL; Shinohara RT; Shuaib A; Mateen FJ
    Int J Stroke; 2014 Apr; 9(3):349-55. PubMed ID: 24207029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of intravenous tissue plasminogen activator in a pediatric patient with acute ischemic stroke.
    Shuayto MI; Lopez JI; Greiner F
    J Child Neurol; 2006 Jul; 21(7):604-6. PubMed ID: 16970853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to letter regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
    Coutts SB; Hill MD
    Stroke; 2015 Jun; 46(6):e150. PubMed ID: 25899240
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
    Liao X; Wang Y; Wang Y
    Stroke; 2014 Dec; 45(12):e304. PubMed ID: 25342031
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
    Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
    Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
    Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter by Zedde et al Regarding Article, "Sex Differences and Functional Outcome After Intravenous Thrombolysis".
    Zedde M; Kremer C; Caso V
    Stroke; 2017 Jul; 48(7):e173-e174. PubMed ID: 28546323
    [No Abstract]   [Full Text] [Related]  

  • 18. Sonothrombolysis: An effective adjunct to intravenous tissue plasminogen activator therapy in acute ischemic stroke.
    Miyachi S
    Neurol India; 2017; 65(1):20-21. PubMed ID: 28084233
    [No Abstract]   [Full Text] [Related]  

  • 19. Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke.
    Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Inoue T; Uemura J; Aoki J
    Stroke; 2008 Aug; 39(8):2388-91. PubMed ID: 18535272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response by Spaander et al to Letter Regarding Article, "Sex Differences and Functional Outcome After Intravenous Thrombolysis".
    Spaander FH; Nederkoorn PJ;
    Stroke; 2017 Nov; 48(11):e330. PubMed ID: 28939670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.